Comparative genomic hybridization analysis of adrenocortical tumors of childhood

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 3, 1999, Pages 1116-1121

  Figueiredo, Bonald C ^a,b   Stratakis, Constantine A ^b,d   Sandrini, Romolo ^a   DeLacerda, Luiz ^a   Pianovsky, Mara A D ^a   Giatzakis, Christoforos ^e   Young, Hannah M ^c,d   Haddad, Bassem R ^c,d  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX TUMOR; ARTICLE; BRAZIL; CANCER STAGING; CHILD; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME ARM; CHROMOSOME LOSS; CHROMOSOME Q BAND; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE LOCUS; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INFANT; MALE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0033032905     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.3.1116     Document Type: Article

References (44)

1. Latronico AC, Chrousos GP. 1997 Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab. 82:1317-1324.
2. Beuschlein F, Reincke M, Karl M, et al. 1994 Clonal composition of human adrenocortical neoplasms. Cancer Res. 54:4927-4932.
3. Henry I, Grandjouan S, Couillin P, et al. 1989 Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci USA. 86:3247-3251.
4. Beckers A, Abs R, Willems PJ, et al. 1992 Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus. J Clin Endocrinol Metab. 75:564-570.
5. Henry I, Jeanpierre M, Couillin P, et al. 1989 Molecular definition of the 11p15.5 region involved in Beckwith-Wiedemann syndrome and probably in predisposition to adrenocortical carcinoma. Hum Genet. 81:273-277.
6. Yano T, Linehan M, Anglard P, et al. 1989 Genetic changes in human adrenocortical carcinomas. J Natl Cancer Inst. 81:518-523.
7. Malkin D, Li FP, Strong LC, et al. 1990 Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 250:1233-1238.
8. Lin SR, Lee YJ, Tsai JH. 1994 Mutations of the p53 gene in human functional adrenal neoplasms. J Clin Endocrinol Metab. 78:483-491.
9. Liu J, Kahri AI, Heikkila P, Voutilainen R. 1997 Ribonucleic acid expression of the clustered imprinted genes, p57KIP2, insulin-like growth factor II, and H19, in adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab. 82:1766-1771.
10. Hatada I, Inazawa J, Abe T, et al. 1996 Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors. Hum Mol Genet. 5:783-788.
11. Ilvesmaki V, Kahri AI, Miettinen PJ, Voutilainen R. 1993 Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas. J Clin Endocrinol Metab. 77:852-858.
12. Liu J, Kahri AI, Heikkila P, Ilvesmaki V, Voutilainen R. 1995 H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab. 80:492-496.
13. Gicquel C, Raffin-Sanson ML, Gaston V, et al. 1997 Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J Clin Endocrinol Metab. 82:2559-2565.
14. Kleihues P, Schauble B, zur Hausen A, Esteve J, Ohgaki H. 1997 Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol. 150:1-13.
15. Wagner J, Portwine C, Rabin K, Leclerc JM, Narod SA, Malkin D. 1994 High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst. 86:1707-1710.
16. Sameshima Y, Tsunematsu Y, Watanabe S, et al. 1992 Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. J Natl Cancer Inst. 84:703-707.
17. Reincke M, Karl M, Travis WH, Mastorakos G, Allolio B, Linehan HM, Chrousos GP. 1994 p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab. 78:790-794.
18. Ohgaki H, Kleihues P, Heitz PU. 1993 p53 mutations in sporadic adrenocortical tumors. Int J Cancer. 54:408-410.
19. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1992 Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:818-821.
20. du Manoir S, Speicher MR, Joos S, et al. 1993 Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet. 90:590-610.
21. Houldsworth J, Chaganti RSK. 1994 Comparative genomic hybridization: an overview. Am J Pathol. 145:1253-1260.
22. Kjellman M, Kallioniemi OP, Karhu R, et al. 1996 Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Res. 56:4219-4223.
23. Luckon AM, Wroclawski ER, Glina S, et al. 1986 Carcinoma da cortex adrenal. Rev Hosp Clin Facc Med Sao Paulo. 41:1-5.
24. Michalkiewicz EL, Sandrini R, Bugg MF, et al. 1997 Clinical characteristics of small functioning adrenocortical tumors in children. Med Pediatr Oncol. 28:175-178.
25. Neblett WW, Frexes-Steed M, Scott HW Jr. 1987 Experience with adrenocortical neoplasms in childhood. Am J Surg. 53:117-125.
26. Hayles AB, Hahn HB Jr, Sprague RG, Bahn RC, Priestley JT. 1966 Hormone-secreting tumors of the adrenal cortex in children. Pediatrics. 37:19-25.
27. Stratakis CA, Chrousos GP. 1997 Endocrine tumors. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology, 3rd ed. Philadelphia: Lippincott; 947-976.
28. Weatherby RP, Carney JA. 1984 Pathologic features of childhoood adrenocortical carcinomas. In: Humphrey GB, Grindey GB, Dehner LP, eds. Adrenal and endocrine tumors in children: adrenal cortical carcinoma and multiple endocrine neoplasia. Boston: Martinus Nijhoff; 239-248.
29. Sandrini R, Ribeiro RC, DeLacerda L. 1997 Childhood adrenocortical tumors. J Clin Endocrinol Metab. 82:2027-2031.
30. Stratakis CA, Jenkins RB, Pras E, et al. 1996 Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex). J Clin Endocrinol Metab. 81:3607-3614.
31. Reincke M, Dohna M, Solinas-Toldo S, Allolio B, LichterP. Multiple chromosomal aberrations in benign, and malignant adrenocortical tumors using comparative genomic hybridization [Abstract P2-108]. Proc of the 79th Annual Meet. of The Endocrine Soc. 1998.
32. Gross K, Pereira MA, Grasso D, et al. 1992 Carcinoma adrenal: relato de 36 casos. Arq Bras Endocr Metab. 36:53-60.
33. Zahm SH, Ward MH. 1998 Pesticides and childhood cancer. Environ Health Perspect. 106(Suppl 3):893-908.
34. Nagao M, Sugimura T. 1993 Carcinogenic factors in food with relevance to colon cancer development. Mutat Res. 290:43-51.
35. Pfeifer GP, Denissenko MF. 1998 Formation and repair of DNA lesions in the p53 gene: relation to cancer mutations? Environ Mol Mutagen. 31:197-205.
36. Sorlie T, Martel-Planche G, Hainaut P, Lewalter J, Holm R, Borresen-Dale AL, Montesano R. 1998 Analysis of p53, p16 MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines. Br J Cancer. 77:1573-1579.
37. Knudson AG. 1992 Heredity and environment in the origin of cancer. Prog Clin Biol Res. 376:31-40.
38. Bartram CR, de Klein A, Hagemeijer A, et al. 1983 Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature. 306:277-280.
39. Chissoe SL, Bodenteich A, Wang YF, et al. 1995 Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal transiocation. Genomics. 27:67-82.
40. Online Mendelian inheritance in man. Center for Medical Genetics, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD). 1997 URL: http://www.ncbi.nlm.nih.gov/omim/.
41. Henske EP, Short MP, Jozwiak S, Bovey CM, Ramlakhan S, Haines JL, Kwiatkowski DJ. 1995 Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1. Ann Hum Genet. 59:25-37.
42. Johnson DW, Qumsiyeh M, Benkhalifa M, Marchuk DA. 1995 Assignment of human transforming growth factor-beta type I and type III receptor genes (TGFBR1 and TGFBR3) to 9q33-q34 and 1p32-p33, respectively. Genomics. 28:356-357.
43. Siemienski K, Peters N, Scheurich P, Wajant H. 1997 Organization of the human tumour necrosis factor receptor-associated factor 1 (TRAF1) gene and mapping to chromosome 9q33-34. Gene. 195:35-39.
44. Chan P, Simon-Chazottes D, Mattei MG, Guenet JL, Salier JP. 1994 Comparative mapping of lipocalin genes in human and mouse: the four genes for complement C8 γ chain, prostaglandin-D-synthase, oncogene-24p3, and progestagen-associated endometrial protein map to HSA9 and MMU2. Genomics. 23:145-150.